Risk factors
BioNexus Gene Lab (BGLC) risk factors
Item 1A of every BioNexus Gene Lab Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors50 risks3 dropped4 reworded
BioNexus dropped cryptocurrency exploration and Chemrex governance transaction risks while updating exposures to Malaysian regulation, economic cycles, and biotech competition.
Filed Apr 14, 2026 - FY2024 10-K risk factors53 risks
MRNA Scientific relies heavily on genomic screening in Malaysia without clinical trials or product liability insurance. Chemrex faces volatile raw material costs and cyclical demand across construction and medical sectors. The company recently expanded its focus to explore business opportunities in the cryptocurrency industry.
Filed Apr 15, 2025